14 High-Risk HPV with 16/18 Genotyping Test Kit

Comprehensive HPV genotyping kit detecting 23 distinct human papillomavirus types including 18 high-risk and 5 low-risk strains. Enables accurate HPV infection characterization for clinical management.

A diagnostic test kit detecting 18 types of human papillomavirus including 14 high-risk types recognized by WHO as causative agents of cervical cancer and 4 medium-risk types associated with cervical cancer, using hybrid capture-chemiluminescence method.

Molecular detection kit for high-risk HPV types 16 and 18. Supports cervical cancer screening and risk stratification.

Specialized kit detecting 16 distinct high-risk HPV genotypes including types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82. Focuses on oncogenic HPV strains for cancer risk assessment.

This diagnostic kit uses real-time multiple fluorescent PCR technology combined with an Automated Fully Enclosed qPCR Instrument. It is used for in vitro qualitative detection of high-risk HPV16, HPV18, and 16 other high-risk types (HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV68, HPV59, HPV66, HPV73, and HPV82) in cervical exfoliated cells or reproductive tract secretions. Test results assist in HPV auxiliary diagnosis.

A molecular PCR test kit for the detection of human papillomavirus types 16 and 18. Used for cervical cancer risk assessment and screening.

Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.

Qualitatively detects high-risk human papillomavirus (HPV) DNA in cervical exfoliate cells or urine samples, including types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82, with specific genotyping identification for types 16 and 18. It uses fluorescent PCR technology and has obtained CE certification.

PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.

Multiplex real-time PCR assay for detection and typing of human papillomavirus with specific genotyping for high-risk types 16 and 18. The kit enables rapid identification of clinically significant HPV variants.

A diagnostic test kit for the detection of human papillomavirus (HPV) nucleic acids. The kit detects 18 types of HPV including 14 high-risk types recognized by the WHO that can lead to cervical cancer, as well as 4 medium-risk types identified by authoritative research as potentially related to cervical cancer. It uses hybridization capture and chemiluminescence methodology.

A qualitative test kit for detecting and genotyping 15 types of human papillomavirus (HPV) DNA in cervical exfoliative cells or urine samples using fluorescent PCR methodology. The kit can identify and differentiate HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, and 73.